ArticleDiscover oncology2026
Hsa_circ_0000231 activates the MAPK pathway via IGF2BP2-mediated CACNA1H mRNA stabilization to promote cervical cancer progression.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCircular RNAs (circRNAs) are key regulators in tumorigenesis, including cervical cancer (CC), but their specific roles and molecular mechanisms in CC remain incompletely understood. This study further explored the functional role of hsa_circ_0000231 in CC cells and its underlying molecular mechanisms.
methodsThe circular nature of circ_0000231 was confirmed using Sanger sequencing, divergent primer PCR, RNase R digestion assay, and subcellular fractionation assay. Gain-of-function experiments involved transfecting SiHa and HeLa cells with circ_0000231-overexpressing plasmids, whereas loss-of-function experiments utilized shRNA-mediated silencing of circ_0000231 in MS751 cells and siRNA-mediated knockdown of CACNA1H in SiHa and HeLa cells. Gene expression levels were verified by qPCR. RNA immunoprecipitation (RIP) assay was used to confirm the direct interactions of circ_0000231 and CACNA1H with IGF2BP2, and mRNA stability assay was employed to evaluate the effect of circ_0000231 and IGF2BP2 on CACNA1H mRNA stability. Cell proliferation, cycle distribution, apoptosis, migration, and invasion were analyzed using MTT, flow cytometry, and Transwell assays, respectively. mRNA transcriptome sequencing was performed to identify differentially expressed genes (DEGs) in CC cells after circ_0000231 overexpression, and protein levels were detected by Western blot.
resultsCompared with non-tumorigenic immortalized human keratinocyte Hacat cells, hsa_circ_0000231 was upregulated in most CC cell lines (HeLa, SiHa, MS751) but not in Caski cells. It exhibited resistance to RNase R digestion and was predominantly localized in the cytoplasm of MS751 cells. Overexpression of circ_0000231 promoted cell proliferation, cell cycle progression, migration, and invasion, while inhibiting apoptosis in CC cells. Conversely, silencing circ_0000231 in MS751 cells exerted the opposite effects. mRNA transcriptome sequencing and KEGG pathway analysis identified the MAPK pathway as an enriched pathway. Intersection analysis of DEGs in HeLa and SiHa cells revealed that CACNA1H, a MAPK pathway-related gene, was upregulated in circ_0000231-overexpressing cells. Silencing CACNA1H reversed the pro-tumor effects of circ_0000231 overexpression, specifically attenuating MAPK pathway activation, restoring apoptosis, and inhibiting cell viability, migration, and invasion. Furthermore, RIP assay confirmed that both circ_0000231 and CACNA1H could bind to IGF2BP2. Knockdown of circ_0000231 or IGF2BP2 significantly reduced the mRNA stability of CACNA1H in MS751 cells, indicating that the hsa_circ_0000231/IGF2BP2 axis enhances CACNA1H mRNA stability.
conclusionsHsa_circ_0000231 acts as an oncogenic circRNA in CC by promoting cell proliferation, migration, and invasion, and activating the MAPK pathway via CACNA1H. Mechanistically, circ_0000231 regulates CACNA1H mRNA stability through binding to IGF2BP2, which clarifies the molecular mechanism underlying circ_0000231-mediated CC progression. These findings extend the current understanding of circ_0000231 regulatory networks in CC and highlight circ_0000231 as a potential therapeutic target.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.